Bulletin from the Annual General Meeting in Enlabs AB

2019-05-23

Download PDF
At the Annual General Meeting (the “AGM”) in Enlabs AB on May 23rd, 2019 the shareholders adopted the following main resolutions:

to determine the presented income statement and balance sheet and the consolidated income statement and the consolidated balance sheet,

to dispose the company's results according to the established balance sheet, in accordance with the Board's proposal in the annual report,

to grant discharge from liability for the fiscal year 2018 for all Board members and the CEO,

to re-elect Niklas Braathen, Staffan Dahl, Christian Haupt, Ludwig Pettersson and Peter Åström as members of the Board of directors,

to re-elect Niklas Braathen as Chairman of the Board,

to approve the proposed board remunerations for the period up to and including the next AGM which shall be SEK 400,000 to the Chairman of the Board and SEK 200,000 to each of the other Board members elected by the Annual General Meeting who do not receive salary from the company,

to re-elect PricewaterhouseCoopers AB to the auditing firm for the period until the end of the annual general meeting, which is due in 2020,

to approve the Board's proposal regarding authorization to the Board of Directors to issue new shares.

Stockholm on May 23, 2019

Enlabs AB

Board of Directors

For questions and for more information, please contact:

Niklas Braathen, Chairman of the Board, +46 705252777, [email protected]

Adam Jonsson, IR manager, +46 738200058, [email protected]

About ENLABS

ENLABS stands for Entertainment Laboratories. We are a company that creates entertainment through innovative thinking within three business areas: Gaming, Media and Solutions. The corporate group has offices in Tallinn, Riga, Vilnius, Malta, Marbella and Stockholm. The operating subsidiaries hold national licenses for their operations and the Group employs approximately 200 employees. ENLABS AB is listed on Nasdaq First North in Stockholm. The company's Certified Adviser is Redeye, +46 (0) 8 121 576 90, [email protected]

For more information, visit enlabs.se

This information was submitted for publication on May 23, 2019 at 12.45.


Subscribe to our press releases & reports